CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+17%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$9.33B
AUM Growth
+$1.78B
(+24%)
Cap. Flow
+$549M
Cap. Flow
% of AUM
5.89%
Top 10 Holdings %
Top 10 Hldgs %
20.52%
Holding
821
New
78
Increased
378
Reduced
271
Closed
33
Top Buys
| 1 |
Microsoft
MSFT
|
$54M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$40.9M |
| 3 |
Intel
INTC
|
$31.2M |
| 4 |
Qualcomm
QCOM
|
$29.1M |
| 5 |
Vipshop
VIPS
|
$28.4M |
Top Sells
| 1 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$53M |
| 2 |
ARQL
Arqule Inc
ARQL
|
$45.5M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$45M |
| 4 |
Arrowhead Research
ARWR
|
$31.8M |
| 5 |
Kodiak Sciences
KOD
|
$17.3M |
Sector Composition
| 1 | Healthcare | 30.73% |
| 2 | Technology | 19.61% |
| 3 | Financials | 10.18% |
| 4 | Consumer Discretionary | 9.32% |
| 5 | Communication Services | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Colgate-Palmolive
CL
$68.8B
| $10.8M | 0.12% |
157,226
+5,059
| +3% | +$348K |
|
|
SAGE
202
DELISTED
Sage Therapeutics
SAGE
| $10.8M | 0.12% |
149,300
+10,000
| +7% | +$722K |
|
203
Exact Sciences
EXAS
$10.2B
| $10.8M | 0.12% |
116,332
+61,690
| +113% | +$5.7M |
|
204
TG Therapeutics
TGTX
$5.11B
| $10.7M | 0.11% |
+959,916
| New | +$10.7M |
|
|
ZGNX
205
DELISTED
Zogenix, Inc.
ZGNX
| $10.6M | 0.11% |
203,700
-67,000
| -25% | -$3.49M |
|
206
Zymeworks
ZYME
$1.14B
| $10.6M | 0.11% |
+232,255
| New | +$10.6M |
|
207
Ambarella
AMBA
$3.54B
| $10.6M | 0.11% |
174,323
+40,646
| +30% | +$2.46M |
|
|
CLVS
208
DELISTED
Clovis Oncology, Inc.
CLVS
| $10.4M | 0.11% |
999,853
-131,270
| -12% | -$1.37M |
|
209
GeoPark
GPRK
$326M
| $10.3M | 0.11% |
468,868
+119,476
| +34% | +$2.63M |
|
|
BHVN
210
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $10.3M | 0.11% |
188,799
-231,000
| -55% | -$12.6M |
|
211
RTX Corp
RTX
$211B
| $10.2M | 0.11% |
107,822
-2,695
| -2% | -$254K |
|
212
Oneok
OKE
$45.7B
| $10.1M | 0.11% |
133,393
+25,535
| +24% | +$1.93M |
|
213
Lincoln National
LNC
$7.98B
| $10M | 0.11% |
170,044
+19,485
| +13% | +$1.15M |
|
214
FibroGen
FGEN
$48.9M
| $9.93M | 0.11% |
9,256
-10,260
| -53% | -$11M |
|
215
Toronto Dominion Bank
TD
$127B
| $9.9M | 0.11% |
176,351
+16,553
| +10% | +$930K |
|
216
Arista Networks
ANET
$180B
| $9.9M | 0.11% |
778,768
-74,448
| -9% | -$946K |
|
|
EIDX
217
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $9.86M | 0.11% |
171,755
-47,245
| -22% | -$2.71M |
|
218
Zimmer Biomet
ZBH
$20.9B
| $9.71M | 0.1% |
66,838
-13,707
| -17% | -$1.99M |
|
219
Regions Financial
RF
$24.1B
| $9.67M | 0.1% |
563,711
+33,080
| +6% | +$568K |
|
220
Williams Companies
WMB
$69.9B
| $9.58M | 0.1% |
403,865
+61,762
| +18% | +$1.47M |
|
|
GTHX
221
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $9.53M | 0.1% |
360,387
+57,887
| +19% | +$1.53M |
|
|
TPTX
222
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $9.51M | 0.1% |
152,628
+119,628
| +363% | +$7.45M |
|
223
General Motors
GM
$55.5B
| $9.4M | 0.1% |
256,887
+129,689
| +102% | +$4.75M |
|
224
Host Hotels & Resorts
HST
$12B
| $9.4M | 0.1% |
506,601
+128,251
| +34% | +$2.38M |
|
225
Cencora
COR
$56.7B
| $9.38M | 0.1% |
110,339
-14,448
| -12% | -$1.23M |
|